Scientists have found a clever new way to make special molecules called α-CF3 allylamines. These molecules are super important in making medicines, pesticides, and other useful materials. The problem was that making them wasn't easy or efficient. The new method uses a special kind of chemistry call
Money in politics is a big problem. It's not just about who wins elections, but also about who has the power to influence decisions. For years, super PACs have been able to collect unlimited amounts of money from wealthy donors. This has led to a system where politicians often prioritize the interes
The Miami Project to Cure Paralysis is more than just a research center; it's a beacon of hope for millions. It all started with a promise to Marc Buoniconti, who was left paralyzed after a football injury. His father, Nick Buoniconti, refused to accept that paralysis was untreatable. This determina
Gut health might be the key to tackling a common liver condition called metabolic dysfunction-associated fatty liver disease (MAFLD). This condition is quite widespread, and it seems that an imbalance in gut bacteria plays a role in its development and worsening. A recent study explored a unique tr
Don Jorgensen, a familiar face in Sioux Falls living rooms for 35 years, is hanging up his microphone. Known for his calm demeanor during crises, like the 1993 plane crash that took Gov. George Mickelson or the 2003 tornado outbreak, Jorgensen has been a steady presence in local news. His award-winn
The COVID-19 vaccine was said to be 95% effective. But what does that really mean? It turns out, the number is not as straightforward as it seems. The 95% figure is based on relative risk reduction. When you look at absolute risk reduction, the picture changes. The actual reduction in risk for the a
Pfizer has been making waves in the pharmaceutical world. It recently outmaneuvered Novo Nordisk to secure a deal for Metsera. This win has given Pfizer's stock a boost. But the company's success isn't just about one deal. Pfizer's third-quarter earnings were impressive. They beat Wall Street's exp
Texas just made a big move against Pfizer. They settled a lawsuit for $41. 5 million. This was about a medicine called Quillivant XR. It's used to treat ADHD in kids. The issue? Tests showed the drug didn't work as it should. It didn't dissolve in the body. But the company kept saying it was fine.
Pfizer's decision to offload its remaining shares in BioNTech (BNTX) has raised eyebrows. This move hints at a lack of faith in BioNTech's COVID-19 vaccine and its stock potential. BioNTech, once a profit powerhouse, is now facing significant losses. Its shares, though not cheap, reflect a company s
India is working hard to create its own tech solutions. The government wants to reduce dependence on foreign tech giants. They have started using local platforms like Zoho Mail, Koo, and Sandes. This push for self-reliance is part of a bigger goal to challenge the U. S. -dominated digital world. Th
